A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Guillermo Garcia-Manero; Nikolai A. Podoltsev; Megan Othus; John M. Pagel; Jerald P. Radich; Min Fang; David A. Rizzieri; Guido Marcucci; Stephen A. Strickland; Mark R. Litzow; M. Lynn Savoie; Bruno C. Medeiros; Mikkael A. Sekeres; Tara L. Lin; Geoffrey L. Uy; Bayard L. Powell; Jonathan E. Kolitz; Richard A. Larson; Richard M. Stone; David Claxton; James Essell; Selina M. Luger; Sanjay R. Mohan; Anna Moseley; Frederick R. Appelbaum; Harry P. Erba

doi:10.1038/s41375-023-02073-x

Back

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Journal article

Peer reviewed

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Guillermo Garcia-Manero, Nikolai A. Podoltsev, Megan Othus, John M. Pagel, Jerald P. Radich, Min Fang, David A. Rizzieri, Guido Marcucci, Stephen A. Strickland, Mark R. Litzow, …

Leukemia

2023-11-07

DOI: https://doi.org/10.1038/s41375-023-02073-x

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.155 Acute Myeloid Leukemia
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
Creators: Guillermo Garcia-Manero
Nikolai A. Podoltsev - Yale University
Megan Othus - Data Management Services
John M. Pagel - Swedish Medical Center
Jerald P. Radich - Fred Hutch Cancer Center
Min Fang - Fred Hutch Cancer Center
David A. Rizzieri - Duke Medical Center
Guido Marcucci - The Ohio State University
Stephen A. Strickland - Vanderbilt University
Mark R. Litzow - Mayo Clinic in Florida
M. Lynn Savoie - Baker Hughes
Bruno C. Medeiros - Stanford University
Mikkael A. Sekeres - Cleveland Clinic
Tara L. Lin - University of Kansas Medical Center
Geoffrey L. Uy - Washington University in St. Louis
Bayard L. Powell - New England Baptist Hospital
Jonathan E. Kolitz - North Shore University Hospital
Richard A. Larson - University of Chicago
Richard M. Stone - Dana-Farber Cancer Institute
David Claxton - Penn State Milton S. Hershey Medical Center
James Essell - Albert Einstein Medical Center
Selina M. Luger - University of Pennsylvania
Sanjay R. Mohan - Sarah Cannon
Anna Moseley - Data Management Services
Frederick R. Appelbaum - Fred Hutch Cancer Center
Harry P. Erba - Duke University
Publication Details: Leukemia
Academic Unit: UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031948391102976